Approvals/TGA/RISPERDAL CONSTA risperidone 37.5mg powder for injection vial with diluent syringe

Approved

STANDARD

RISPERDAL CONSTA risperidone 37.5mg powder for injection vial with diluent syringe

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 37ddc5d57ba5fdd9
Product Name: RISPERDAL CONSTA risperidone 37.5mg powder for injection vial with diluent syringe
Artg Id: 81490
Artg Name: RISPERDAL CONSTA risperidone 37.5mg powder for injection vial with diluent syringe
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2003-04-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/512d249ce871e302a00b3dc7ac7e449e.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/8b272d77e371fd9af03ddf6e4560bcdc.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

37ddc5d57ba5fdd9

Type

Standard